HCW Biologics Files 8-K on Corporate Matters
Ticker: HCWB · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1828673
Sentiment: neutral
Topics: corporate-governance, regulatory-filing
TL;DR
HCW Biologics filed an 8-K on April 1st for votes and other events.
AI Summary
HCW Biologics Inc. filed an 8-K on April 1, 2025, reporting on matters submitted to a vote of security holders and other events. The filing details the company's corporate actions and significant events that occurred on or before April 1, 2025. Specific details regarding the nature of the vote or the other events are not elaborated in the provided text.
Why It Matters
This filing indicates significant corporate actions or decisions have been made by HCW Biologics Inc., which could impact its operations, governance, or future strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information about financial distress, significant legal issues, or major operational changes.
Key Players & Entities
- HCW Biologics Inc. (company) — Registrant
- 20250401 (date) — Date of earliest event reported
- April 01, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-40591 (commission_file_number) — SEC File Number
- 82-5024477 (ein) — IRS Employer Identification No.
- 2929 N. Commerce Parkway (address) — Principal Executive Offices
- Miramar (city) — Principal Executive Offices
- Florida (state) — Principal Executive Offices
- 33025 (zip_code) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of security holders?
The provided text of the 8-K filing does not specify the exact matters that were submitted to a vote of security holders.
What were the 'Other Events' reported in this 8-K?
The filing indicates 'Other Events' were reported, but the specific nature of these events is not detailed in the provided excerpt.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 01, 2025.
What is HCW Biologics Inc.'s principal executive office address?
HCW Biologics Inc.'s principal executive office is located at 2929 N. Commerce Parkway, Miramar, Florida 33025.
What is the SEC file number for HCW Biologics Inc.?
The SEC file number for HCW Biologics Inc. is 001-40591.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding HCW Biologics Inc. (HCWB).